Introduction:
Ventricular Septal Defect (VSD) is the most commonly encountered congenital lesion reported in most cardiac centers. 1 It accounts for 35% of all congenital heart lesions in Bristol Seris. 2 The incidence of VSD in all live birth is approximately 1.5 to 3.5 per 1000 term infants and 4.5 to 7 per thousands premature infants. 3, 4 Surgical closure of haemodynamically significant VSD's has long been established worldwide. Device closure of VSD is less well accepted and can only be regarded as an option for very selected cases, and available in a small number of centres worldwide. 5, 6 This procedure is complicated, needs presence of at least three cardiologists for smooth running of the operation. One cardiologist and two cath lab nurse had performed this case under the guide of transthoracic echo and fluoroscopy. Deep sedation with Ketamine was given. An Anaesthesiologist was kept ready for giving general aneasthesia at the time of requirement but it was not needed at all.
Case Report:
Miss T, an eight years old girl was diagnosed as a case of perimembranous VSD since 6 months of her age. She had history of repeated hospital admission with respiratory tract infection. Initially VSD was large and it was 7 mm in size. On her subsequent follow up size of VSD gradually reduced. She had mild degree of growth failure also. Her pulmonary artery systolic pressure was measure its distance from aortic valve. A JR-4 catheter was introduced through RFA and VSD was crossed easily with Terumo wire. Terumo wire was exchanged with long exchange wire and it was snared from main pulmonary artery. Exchange wire was taken out of the body through RFV in such a way that a loop was formed with exchange wire all the way from RFA through left and right ventricle and then it came out through RFV. A torque delivery system was than introduced through RFV to aortic root and it was then dropped to LV in such a way that tip of sheath should points towards LV apex. Perimembranous VSD device was than loaded to loader with the help of delivery cable and pusher catheter. Loader was than connected to delivery sheath carefully to avoid air bubbles. Whole system was than forwarded through delivery sheath to LV. LV disc was released under transthoracic and fluoroscopy guide. Whole system was withdrawn carefully and RV disc was released. Patient was discharged from hospital 72 hours after procedure with follow up appointment at 1, 3, 6, 9, 12, 18, 24 months and yearly thereafter for three years. 
Fig-2: Chest X-ray showing PM VSD Device

Discussion:
The procedure for percutaneous closure of VSD with intracardiac device was first attempted by lock et al in 1988 and originally designed devices were used with a variable success rate. 6, 7 Device option used for VSD closure were Rashkind device, VSD OS, Amplatzer VSD device and cardio seal. The Amplatzer VSD occluder has been undergoing clinical trial since 1988 after the animal experiments had shown 100% occlusion and complete endothelization at three months. 8 In 2002, Hijazi et al reported the initial human use in six patients with complete closure in all and the absence of any significant complications. In this case we use Amplatzer PM VSD occluder of 8 mm size in the waist and 14 mm and 12 mm on LV and RV side respectively. A study was conducted in Asabu University, Japan where coil was used for closing VSD's in dogs. They concluded that trans catheter closure of small perimembranous VSD with detachable coil can be performed without major complications. 9 A study conducted in Brazil proved that percutaneous closure of perimembranous VSD with Amplatzer occluder is safe, feasible and effective. 10 This study concluded that Amplatzer PM VSD occluder was suitable to close a wide range of perimembranous VSD with various size and morphologies with good short term outcomes. In this case we used Amplatzer PM VSD occluder. This device is used in several center of the world now with good short term outcomes. It will need some time to get long term outcomes of these cases. In our center first case of perimembranous VSD was performed in August 2004. All the cases (20) performed since then are doing very well. No complications are encountered yet in follow up of these cases.
Conclusion:
VSD device closure procedure still remains challenging and controversial. However, there are a small group of children with VSD's that are difficult to close surgically and involve substantially higher risk. These defects can be closed with devices. Many patients, specially females do not want any scar in the chest. Those cases can be done if there is no associated problems like aortic valve prolapse, infundibular stenosis etc. Surgically inaccessible VSD and multiple VSD's is good candidate for device. Hybrid procedure for closing VSD is now practiced in many center of the world, where surgeon do thoracotomy and paediatric cardiologist introduce device by directly cannulating heart. In our center we prefer device closure if the candidate fulfilled the criteria for it completely.
